海洋生物技術市場規模、佔有率、成長分析、按類型、技術、應用、最終用戶、地區 - 產業預測，2025-2032 年

2023 年全球海洋生物技術市場規模價值 65 億美元，預計將從 2024 年的 69.5 億美元成長到 2032 年的 118.5 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

全球海洋生物技術市場正在崛起，利用海洋資源徹底改變醫療、農業和能源領域。這個快速成長的產業是由對永續和環保替代品的需求、慢性病的增加以及對再生能源來源的追求所驅動。然而，研發成本高、海洋資源取得管道有限以及監管障礙等挑戰阻礙了快速成長。然而，生物技術和基因組學的進步以及產學研合作的不斷加強將有助於擴大市場。全球主要趨勢包括在工業過程中採用海洋酶以及對用於醫療和組織工程應用的海洋生醫材料的興趣日益濃厚，這表明在全球永續性要求日益提高的背景下，存在巨大的成長和創新機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

海洋生物技術市場規模（按類型）

• 市場概況
• 生物活性物質
• 生醫材料

海洋生物技術市場規模（依技術分類）

• 市場概況
• 微生物分離與培養
• 文化獨立的技術

海洋生物技術市場規模（按應用）

• 市場概況
• 水產養殖和食品
• 環境與人類健康
• 藥物研發

海洋生物技術市場規模（按最終用戶分類）

• 市場概況
• 食品工業
• 製藥和生物技術產業
• 化工
• 化妝品產業

海洋生物技術市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• BASF（Germany）
• Key Developments
• Cyanotech Corp.（USA）
• Kerry Group（Ireland）
• Corbion（Netherlands）
• FMC Corp.（USA）
• Marine Biotech（USA）
• Royal DSM（Netherlands）
• TransGen Biotech Co., Ltd.（China）
• Olmix Group（France）
• Ittinsect（Italy）
• BRAIN Biotech AG（Germany）
• Biotech Marine（France）
• Marinova Pty Ltd（Australia）
• Pharma Mar, SA（Spain）
• GlycoMar Ltd.（UK）
• Aker BioMarine ASA（Norway）
• oceanBASIS GmbH（Germany）
• Primex Iceland（Iceland）
• New England Biolabs（NEB）（USA）

結論和建議

Global Marine Biotechnology Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 6.95 billion in 2024 to USD 11.85 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global marine biotechnology market is on an upward trajectory, leveraging oceanic resources to innovate in medicine, agriculture, and energy sectors. This burgeoning industry is driven by the demand for sustainable, eco-friendly alternatives, heightened chronic disease prevalence, and the pursuit of renewable energy sources. Yet, challenges such as high R&D costs, limited access to marine resources, and regulatory barriers impede rapid growth. Nonetheless, advancements in biotechnology and genomics, along with rising collaborations between industry and research organizations, are poised to propel market expansion. Key trends include the adoption of marine-derived enzymes in industrial processes and a growing interest in marine biomaterials for applications in medicine and tissue engineering, suggesting significant opportunities for growth and innovation as global sustainability imperatives intensify.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Marine Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Marine Biotechnology Market Segments Analysis

Global Marine Biotechnology Market is segmented by Type, Technology, Application, End-user and region. Based on Type, the market is segmented into Bio Active Substance and Bio Materials. Based on Technology, the market is segmented into Isolation and Cultivation of Microorganisms and Culture-Independent Techniques. Based on Application, the market is segmented into Aquaculture and Food Products, Environment & Human Health and Drug Discovery. Based on End-user, the market is segmented into Food Industry, Pharmaceutical and Biotechnology Industry, Chemical Industry and Cosmetic Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Marine Biotechnology Market

Rising awareness of environmental issues and the push for sustainability are driving demand for eco-friendly products in numerous sectors. Marine biotechnology emerges as a key player in this movement, providing sustainable solutions like marine-derived enzymes for industrial uses, alongside biofuels and bioplastics. One notable example is Algix, a company that creates biodegradable bioplastic materials sourced from algae, presenting a sustainable alternative to conventional plastics. The integration of these innovative marine-derived solutions is not only addressing ecological concerns but also promoting a transition towards greener practices across various industries, highlighting the significant role of marine biotechnology in the global market.

Restraints in the Global Marine Biotechnology Market

The Global Marine Biotechnology market faces significant limitations due to the extensive research and development required for product innovation. This process includes identifying and cultivating marine organisms, alongside extracting and purifying bioactive compounds. Such intricate procedures come with high costs, which can hinder the growth and commercialization of marine biotechnology products. For instance, the cultivation and extraction of just one marine-derived compound can incur expenses totaling several hundred thousand dollars. This financial challenge poses a barrier for many companies seeking to enter and thrive in the market, ultimately impacting the industry's overall expansion and profitability.

Market Trends of the Global Marine Biotechnology Market

The Global Marine Biotechnology market is witnessing a significant trend towards the utilization of marine-derived biomaterials, driven by their unique properties and diverse applications in medicine, tissue engineering, and regenerative therapies. Innovations such as marine collagen, noted for its enhanced biocompatibility and biological functionality compared to traditional mammalian alternatives, are gaining traction in wound healing and tissue regeneration processes. The shift towards sustainable and biodegradable materials, coupled with increased research and development efforts, is propelling the demand for these biomaterials. This emerging trend highlights the potential of marine resources to revolutionize healthcare solutions and drive growth within the marine biotechnology sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Marine Biotechnology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Bio Active Substance
• Bio Materials

Global Marine Biotechnology Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Global Marine Biotechnology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery

Global Marine Biotechnology Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Food Industry
• Pharmaceutical and Biotechnology Industry
• Chemical Industry
• Cosmetic Industry

Global Marine Biotechnology Market Size & CAGR (2025-2032)

• North America (Type, Technology, Application, End-user)
  • US
  • Canada
• Europe (Type, Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Cyanotech Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corbion (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Biotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olmix Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ittinsect (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BRAIN Biotech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotech Marine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marinova Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Mar, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMar Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aker BioMarine ASA (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• oceanBASIS GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primex Iceland (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (NEB) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations